News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Revolution Medicines Receives FDA Breakthrough Therapy Designation for Daraxonrasib in Advanced Pancreatic Cancer with KRAS G12 Mutations
Tuesday, June 24, 2025Revolution Medicines Inca latestage clinical oncology firm focused on targeted therapies for RASdriven cancers has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation
DATROWAY® Approved in the U.S. as First TROP2-Directed Treatment for Advanced EGFR-Mutated Lung Cancer
Tuesday, June 24, 2025DATROWAY datopotamab deruxtecandlnk has received accelerated approval in the United States for the treatment of adults with locally advanced or metastatic nonsmall cell lung cancer NSCLC harbouring EGFR mutations
Archeus Technologies Receives FDA Clearance for Investigational Prostate Cancer Therapy ART-101
Saturday, June 21, 2025Archeus Technologies a company focused on developing radiopharmaceutical treatments for cancer has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for ART
Incyte Gains FDA Approval for Monjuvi® in Follicular Lymphoma Treatment
Friday, June 20, 2025Incyte has received approval from the US Food and Drug Administration FDA for Monjuvi tafasitamabcxix in combination with rituximab and lenalidomide for use in adults with relapsed or refractory follicular lymphoma
RyboDyn Joins Lilly Gateway Labs to Advance Novel Immunotherapies Targeting the Dark Proteome
Friday, June 20, 2025RyboDyn Inc a biotechnology company focused on developing new immunotherapies aimed at the dark proteome has been selected to join Lilly Gateway Labs LGL in San Diego Operated in partnership
Advarra Forms AI Council with Life Sciences Experts to Promote Responsible Use of Artificial Intelligence in Clinical Trials
Thursday, June 19, 2025Advarra a leader in clinical research technology and regulatory review has launched the Council for Responsible Use of AI in Clinical Trials This newly formed group brings together experts from the life sciences industry to set standards
FDA Grants Orphan Drug Designation to Medicovestor’s Innovative ADC for Pancreatic Cancer
Wednesday, June 18, 2025Medicovestor Inc a biotechnology company focused on the development of advanced antibodydrug conjugates ADCs has received Orphan Drug Designation ODD from the US Food and Drug Administration
Ferrer Receives FDA Fast Track Designation for FNP-223 to Treat Progressive Supranuclear Palsy
Wednesday, June 18, 2025Ferrer a global pharmaceutical company and certified B Corp has received Fast Track designation from the US Food and Drug Administration FDA for FNP a treatment aimed at slowing the progression
Circle Pharma Secures FDA Orphan Drug Designation for CID-078 to Treat Small Cell Lung Cancer
Tuesday, June 17, 2025Circle Pharma a clinicalstage biopharmaceutical firm focused on macrocyclebased cancer therapies has received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for its investigational therapy CID for the treatment of small cell...
Teva and Fosun Pharma Form Strategic Partnership to Advance Development of TEV-56278 in Cancer Immunotherapy
Tuesday, June 17, 2025Teva Pharmaceutical Industries Ltd and Shanghai Fosun Pharmaceutical Group Co Ltd have announced a strategic collaboration through their respective subsidiaries for the development of TEV
